NEW TARGETED IMMUNOTHERAPIES FOR

SOLID TUMORS

ABOUT US 

 

CT is specialized in cancer immunotherapies and antibody-drug conjugates for the treatment of solid tumor. CT has developed innovative technologies to generate NK cell-based targeted immunotherapies

TECHNOLOGY

 

CT's platform allows engineering of NK cells into targeted chemoimmunotherapy for various cancers

 

PARTNERSHIP

Welcome and Thank you for your interest in Partnering with us.

We would like to invite you to have a look at our Technology.

 We are open to further discussion.

CONTACT US

Thanks for submitting!